Cargando…

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants

The association of SLCO1B1 c.521T>C with simvastatin-induced muscle toxicity is well characterized. However, different statins are subject to metabolism and transport also by other proteins exhibiting clinically meaningful genetic variation. Our aim was to investigate associations of SLCO1B1 c.52...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lönnberg, K. Ivar, Tornio, Aleksi, Hirvensalo, Päivi, Keskitalo, Jenni, Mustaniemi, Anna-Liina, Kiiski, Johanna I., Filppula, Anne M., Niemi, Mikko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399933/ https://www.ncbi.nlm.nih.gov/pubmed/37490620 http://dx.doi.org/10.1097/FPC.0000000000000504

Ejemplares similares

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans
por: Neuvonen, Mikko, et al.
Publicado: (2021)

Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation
por: Tornio, Aleksi, et al.
Publicado: (2019)

Pharmacogenomics of celiprolol – evidence for a role of P‐glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics
por: Hirvensalo, Päivi, et al.
Publicado: (2021)

Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans
por: Itkonen, Matti K., et al.
Publicado: (2017)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics
por: Hirvensalo, Päivi, et al.
Publicado: (2017)

Initial statin dose after myocardial infarction and long-term cardiovascular outcomes
por: Kytö, Ville, et al.
Publicado: (2022)

Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin
por: Lehtisalo, Minna, et al.
Publicado: (2020)

Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers
por: Neuvonen, Mikko, et al.
Publicado: (2020)

Lack of Statin Therapy and Outcomes After Ischemic Stroke: A Population-Based Study
por: Åivo, Julia, et al.
Publicado: (2023)

Common Statin Intolerance Variants in ABCB1 and LILRB5 Show Synergistic Effects on Statin Response: An Observational Study Using Electronic Health Records
por: Melhem, Alaa’ Lutfi, et al.
Publicado: (2021)

A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance
por: Bigossi, Margherita, et al.
Publicado: (2023)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
por: Rattanacheeworn, Punyabhorn, et al.
Publicado: (2020)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
por: Li, Qian, et al.
Publicado: (2019)

Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction
por: Tapaninen, Tuija, et al.
Publicado: (2019)

The cholesterol-lowering effect of statins is modified by LILRB5 intolerance genotype: Results from a recruit-by-genotype clinical trial
por: Tornio, Aleksi, et al.
Publicado: (2023)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

A common missense variant of LILRB5 is associated with statin intolerance and myalgia
por: K Siddiqui, Moneeza, et al.
Publicado: (2017)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

Pharmacogenetics of Statin-Induced Myotoxicity
por: Kee, Ping Siu, et al.
Publicado: (2020)

Management of statin intolerance
por: Raju, Soma B., et al.
Publicado: (2013)

Insights Into Statin Intolerance
por: Kopecky, Stephen, et al.
Publicado: (2015)

Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
por: Itkonen, Matti K., et al.
Publicado: (2018)

Placental transporter‐mediated drug interactions and offspring congenital anomalies
por: Ellfolk, Maria, et al.
Publicado: (2020)

Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation
por: Kytö, Ville, et al.
Publicado: (2022)

Genetic determinants of statin intolerance
por: Oh, Jisun, et al.
Publicado: (2007)

Treating statin-intolerant patients
por: Arca, Marcello, et al.
Publicado: (2011)

Intolerance to Statins: Mechanisms and Management
por: Bitzur, Rafael, et al.
Publicado: (2013)

Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016)

Statin Intolerance: the Clinician’s Perspective
por: Stulc, Tomáš, et al.
Publicado: (2015)

Diagnosis and Management of Statin Intolerance
por: Alonso, Rodrigo, et al.
Publicado: (2019)

Statin Intolerance—An Asian Perspective
por: Tomlinson, Brian, et al.
Publicado: (2020)

Investigating Real‐World Clopidogrel Pharmacogenetics in Stroke Using a Bioresource Linked to Electronic Medical Records
por: Tornio, Aleksi, et al.
Publicado: (2017)

Statin Intolerance and Vitamin D Supplementation
por: Khayznikov, Maksim, et al.
Publicado: (2015)

Statin Intolerance Clinical Guide 2018
por: Kajinami, Kouji, et al.
Publicado: (2020)

SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study
por: Luo, Jian-Quan, et al.
Publicado: (2015)

Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter ABCG2
por: Ripperger, Anne, et al.
Publicado: (2018)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2i073679sct1pcqnjlbjco8pg2